Your Enrollment Form request has been submitted to IPSEN CARES for review. A Patient Access Specialist will review your submission and contact both you and your Healthcare Provider within 1 business day. If you have any questions or would like to learn more about IPSEN CARES and its support offerings, please call 866-435-5677, 8:00am to 8:00pm ET Monday through Friday.
Please note: This form will take 10 minutes to complete. There is a requirement for two signatures - first the patient, then the HCP office.
Instructions for Patients
- Your Healthcare Provider will complete the Steps Outlined in Green.
- You need to complete Steps 1, 2, 3 and 7 Outlined in Blue on the Enrollment Form.
- Fill out all sections completely. Required fields must be completed prior to submission of the form.
- Required fields are marked with an asterisk.
- STEP 1: Fill out the Patient Information Section in Step 1.
- STEP 2: Fill out the Insurance Information Section in Step 2.
- STEP 3: Fill out the IPSEN CARES Copay Program Section in Step 3.
- STEP 4: Sign the PATIENT AUTHORIZATION AND ADDITIONAL PRODUCT AND SUPPORT INFORMATION box under Step 3 after you read the information in Step 7.
Instructions for Prescribers
- Fill out the Prescriber Information Sections in Steps 4-6.
- Sign and date the PRESCRIBER ATTESTATION at the end of Step 6B.
- Required fields are marked with an asterisk.
Once a completed Enrollment Form is received, an IPSEN CARES Patient Access Specialist will perform a benefits verification and review the patient’s coverage and out-of-pocket responsibility with both the HCP and the patient typically within 1 business day. To learn more about IPSEN CARES and support offerings, please call 866-435-5677, 8:00 am to 8:00 pm ET Monday through Friday or visit www.ipsencares.com.
We are collecting personal information in order to fulfill your request. Please see Ipsen’s privacy policy at https://www.ipsen.com/us/privacy-policy/.
ONIVYDE is a registered trademark of Ipsen Biopharm Limited.
IPSEN CARES is a registered trademark of Ipsen S.A.
©2021 Ipsen Biopharmaceuticals, Inc. September 2021 ONV-US-002162 V 2.0
Please see accompanying full Prescribing Information, including Boxed WARNING.